Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cellsSCHUMACHER, Jonathan A; CROCKETT, David K; ELENITOBA-JOHNSON, Kojo S. J et al.Proteomics (Weinheim. Print). 2007, Vol 7, Num 15, pp 2603-2616, issn 1615-9853, 14 p.Article

Identification of NPM-ALK interacting proteins by tandem mass spectrometryCROCKETT, David K; ZHAOSHENG LIN; ELENITOBA-JOHNSON, Kojo S. J et al.Oncogene (Basingstoke). 2004, Vol 23, Num 15, pp 2617-2629, issn 0950-9232, 13 p.Article

Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphomaAMIND, Hesham M; MEDEIROS, L. Jeffrey; MA, Yupo et al.Oncogene (Basingstoke). 2003, Vol 22, Num 35, pp 5399-5407, issn 0950-9232, 9 p.Article

Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinaseTURNER, Suzanne D; TOOZE, Reuben; MACLENNAN, Kenneth et al.Oncogene (Basingstoke). 2003, Vol 22, Num 49, pp 7750-7761, issn 0950-9232, 12 p.Article

Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomasCOLOMBA, A; COURILLEAU, D; RAME, D et al.Oncogene (Basingstoke). 2008, Vol 27, Num 19, pp 2728-2736, issn 0950-9232, 9 p.Article

Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ ERK signaling pathway independently of c-RafMARZEC, M; KASPRZYCKA, M; LIU, X et al.Oncogene (Basingstoke). 2007, Vol 26, Num 6, pp 813-821, issn 0950-9232, 9 p.Article

The oncogenic fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation modelMIETHING, Cornelius; GRUNDLER, Rebekka; FEND, Falco et al.Oncogene (Basingstoke). 2003, Vol 22, Num 30, pp 4642-4647, issn 0950-9232, 6 p.Article

Immunochemical studies of antigenic lymphoma-associated proteinsPULFORD, Karen; ROBERTON, Helen; BANHAM, Alison H et al.British journal of haematology. 2002, Vol 116, Num 1, pp 135-141, issn 0007-1048Article

Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1PULFORD, K; LAMANT, L; MORRIS, S. W et al.Blood. 1997, Vol 89, Num 4, pp 1394-1404, issn 0006-4971Article

Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five casesLAMANT, Laurence; PILERI, Stefano; SABATTINI, Elena et al.Haematologica (Roma). 2010, Vol 95, Num 3, pp 449-455, issn 0390-6078, 7 p.Article

Mice transgenic for NPM-ALK develop non-hodgkin lymphomasJÄGER, Richard; HAHNE, Jens; JACOB, Andrea et al.Anticancer research. 2005, Vol 25, Num 5, pp 3191-3196, issn 0250-7005, 6 p.Article

Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomasTHORNBER, K; COLOMBA, A; CECCATO, L et al.Oncogene (Basingstoke). 2009, Vol 28, Num 29, pp 2690-2696, issn 0950-9232, 7 p.Article

Identification of multiple SNT-binding sites on NPM-ALK oncoprotein and their involvement in cell transformationCHIKAMORI, M; FUJIMOTO, J; TOKAI-NISHIZUMI, N et al.Oncogene (Basingstoke). 2007, Vol 26, Num 20, pp 2950-2954, issn 0950-9232, 5 p.Article

What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?TURNER, S. D; ALEXANDER, D. R.Leukemia. 2005, Vol 19, Num 7, pp 1128-1134, issn 0887-6924, 7 p.Article

The effect of the cyclin-dependent kinase inhibitor flavopiridol on anaplastic large cell lymphoma cells and relationship with NPM-ALK kinase expression and activityBONVINI, Paolo; ZORZI, Elisa; MUSSOLIN, Lara et al.Haematologica (Roma). 2009, Vol 94, Num 7, pp 944-955, issn 0390-6078, 12 p.Article

Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cellsTURNER, S. D; ALEXANDER, D. R.Leukemia. 2006, Vol 20, Num 4, pp 572-582, issn 0887-6924, 11 p.Article

β-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphomaANAND, Mona; LAI, Raymond; GELEBART, Pascal et al.Haematologica (Roma). 2011, Vol 96, Num 2, pp 253-261, issn 0390-6078, 9 p.Article

Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK⁺ anaplastic large cell lymphomaDIEN BARD, J; GELEBART, P; ANAND, M et al.Leukemia. 2008, Vol 22, Num 8, pp 1595-1603, issn 0887-6924, 9 p.Article

Determining the contribution of NPM1 heterozygosity to NPM-ALK-induced lymphomagenesisMCDUFF, Fiona Ke; ELIZABETH HOOK, C; TOOZE, Reuben M et al.Laboratory investigation. 2011, Vol 91, Num 9, pp 1298-1303, issn 0023-6837, 6 p.Article

CD2 promoter regulated nucleophosmin-anaplastic lymphoma kinase in transgenic mice causes B lymphoid malignancyTURNER, Suzanne D; MERZ, Hartmut; YEUNG, Debra et al.Anticancer research. 2006, Vol 26, Num 5A, pp 3275-3279, issn 0250-7005, 5 p.Article

Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphomaMUSSOLIN, L; PILLON, M; D'AMORE, E. S et al.Leukemia. 2005, Vol 19, Num 9, pp 1643-1647, issn 0887-6924, 5 p.Article

Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30⁺ NPM―ALK⁺ anaplastic large-cell lymphomasBONVINI, P; ZORZI, E; MUSSOLIN, L et al.Leukemia. 2012, Vol 26, Num 6, pp 1375-1382, issn 0887-6924, 8 p.Article

Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlationDAMM-WELK, Christine; KLAPPER, Wolfram; OSCHLIES, Ilske et al.British journal of haematology. 2009, Vol 146, Num 3, pp 306-309, issn 0007-1048, 4 p.Article

Selective inhibition of STAT3 induces apoptosis and G₁ cell cycle arrest in ALK-positive anaplastic large cell lymphomaAMIN, Hesham M; MCDONNELL, Timothy J; MEDEIROS, L. Jeffrey et al.Oncogene (Basingstoke). 2004, Vol 23, Num 32, pp 5426-5434, issn 0950-9232, 9 p.Article

Model of inhibition of the NPM-ALK kinase activity by herbimycin ATURTURRO, Francesco; ARNOLD, Marilyn D; FRIST, Audrey Y et al.Clinical cancer research. 2002, Vol 8, Num 1, pp 240-245, issn 1078-0432Article